OR WAIT null SECS
March 03, 2023
EnteroBiotix is harnessing the power of the microbiome to target an array of diseases.
PAT is crucial to process control and real-time release in continuous manufacturing of solid-dosage drugs.
March 02, 2023
Technological advances will help ease pressure on pharma supply chains, allowing for greater visibility and less uncertainty.
Lilly will cap insulin prices for patients with and without insurance at $35 per month.
Soaring energy costs are compounding the challenges currently being faced by the European bio/pharma industry.
March 01, 2023
AstraZeneca has entered into a global exclusive license agreement with KYM Biosciences for CMG901, which is being investigated as a gastric cancer treatment.
CHMP recommended the approval of AbbVie’s RINVOQ (upadacitinib) as a treatment for adults with moderate-to-severe Crohn’s disease.
February 28, 2023
Moderna and Merck’s investigational personalized mRNA cancer vaccine has been granted Breakthrough Therapy Designation by FDA.
February 27, 2023
WHO is appealing for US $392 million to reach 12.9 million people with essential health assistance in 2023.
Orchard Therapeutics has announced an agreement which will enable reimbursed access to Libmeldy for all eligible MLD patients in Sweden.